Home
|
Search For Specialist
|
Clinical Trials in US
|
Clinical Trials Worldwide
|
Blog
Find Clinical and Medical Trials for Hepatitis C
<<
Previous
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
Next
>>
IMPROVE Study(The Individualized Management With PEGASYS and Ribavirin Offering Viral Eradication): A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Non-Genotype 2/3. - 13124
Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C - 13134
Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant - 13145
Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Patients With/Without Substitution Therapy (Study P05255) - 13147
ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (Study P05632AM1) - 13151
A Multicentre Phase III Study of Interferon-Beta-1a for the Treatment of Chronic Hepatitis C in Asian Patients - 13152
Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)(COMPLETED) - 13198
Phase II Trial of Silymarin for Non-Cirrhotic Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment - 13202
Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis - 13216
Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients - 13279
Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients - 13282
Short Course of Interferon Treatment in Patients With HCV Infection - 13302
TMC435-TiDP16-C205: A Phase II Study of TMC435 in Combination With Pegylated Interferon Alpha-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment - 13310
Three-Year Follow-up of Subjects After Administration of Boceprevir for the Treatment of Chronic Hepatitis C (Study P05063) - 13314
Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016) - 13319
<<
Previous
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
Next
>>
Search For Specialist
Doctors And Specialists
Allergists
Anesthesiologists
Cardiologists
Dermatologists
Emergencymedicine
Endocrinologists
Familypractice
Gastroenterologists
Generalpractice
Geriatrics
Gynecologists
Infectiousdisease
Internalmedicine
Medicalgenetics
Nephrologists
Neurological
Neurologists
Oncologists
Ontolaryngologists
Ophthalmologists
Orthopedics
Other
Pathologists
Pediatrics
Plasticsurgery
Preventative
Psychiatrists
Radiologists
Rehabilitation
Surgeons
Urologists
Select State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Types of Treatments
Cancer Treatment
Breast cancer treatment
Lung cancer treatment
Cancer insurance
Prostate cancer treatment
Laser Treatment
Eye laser treatment
Laser tattoo removal treatment
Cheap laser treatment
Laser treatment for hair removal
Laser surgery
Laser hair loss treatment
Laser treatments to quit smoking
Laser skin care treatment
Chemotherapy
Treatments chemotherapy side effects
Types of chemotherapy
Chemotherapy drug
Adjuvant chemotherapy
Search Trials By
Condition Categories
Bacterial and Fungal Diseases
Behaviors and Mental Disorders
Blood and Lymph Conditions
Cancers and Other Neoplasms
Digestive System Diseases
Diseases and Abnormalities at or before Birth
Ear, Nose, and Throat Diseases
Eye Diseases
Gland and Hormone Related Diseases
Heart and Blood Diseases
Immune System Diseases
Injuries, Poisonings, and Occupational Conditions
Mouth and Tooth Diseases
Muscle, Bone, and Cartilage Diseases
Nervous System Diseases
Nutritional and Metabolic Diseases
Parasitic Diseases
Respiratory Tract (Lung and Bronchial) Diseases
Skin and Connective Tissue Diseases
Symptoms and General Pathology
Urinary Tract, Sexual Organs, and Pregnancy Conditions
Viral Diseases
Intervention Categories
Alcohol Deterrents
Analgesics, Narcotic
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Dyskinesia Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Obesity Agents
Anticoagulants
Anticonvulsants
Antiemetics
Antihypertensive Agents
Antilipemic Agents
Antineoplastic Agents
Antirheumatic Agents
Antisickling Agents
Blood Substitutes
Bone Density Conservation Agents
Cardiotonic Agents
Central Nervous System Depressants
Central Nervous System Stimulants
Channel Blockers
Coagulants
Dermatologic Agents
Fibrinolytic Agents
Gastrointestinal Agents
Hematinics
Hypnotics and Sedatives
Hypoglycemic Agents
Micronutrients
Muscle Relaxants, Central
Narcotic Antagonists
Natriuretic Agents
Neuroprotective Agents
Nitric Oxide Donors
Nootropic Agents
Platelet Aggregation Inhibitors
Psychotropic Drugs
Renal Agents
Reproductive Control Agents
Respiratory System Agents
Vasoconstrictor Agents
Vasodilator Agents
Research
Fundamentals of Clinical Trial
Clinical Trials For Cancer
Clinical Trial For Other Disease
Most Popular Trials
Back Pain (2305)
Breast Cancer (19572)
Cardiac (5855)
Endometriosis (365)
Hepatitis C (5951)
Lung Cancer (20549)
Lymphoma (41171)
Melanoma (7124)
Microscopic Colitis (12)
Ovulation (278)
Prostate Cancer (13431)
Psoriasis (1822)
Retinoblastoma (302)
Weight Loss (3144)
Library
Free Cancer Information EBooks
Free Weight Loss Information EBooks
Free Disease Information EBooks
Free Health & Fitness Information EBooks
Free Health Disorder Information EBooks
Discuss
Anxiety and Stress
Fitness Problems
Birth Control
Skin Disorder
Back Pain